Trials / Suspended
SuspendedNCT04245917
Natural History Study of MNGIE
Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Entrada Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-interventional | Non-interventional natural history study |
Timeline
- Start date
- 2020-08-06
- Primary completion
- 2025-02-01
- Completion
- 2026-02-01
- First posted
- 2020-01-29
- Last updated
- 2021-07-22
Locations
5 sites across 2 countries: United States, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04245917. Inclusion in this directory is not an endorsement.